
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-6.82%
+2.63%
+16.42%
+10.84%
+2.79%
18 Feb 2026$AR Jefferies resumed coverage of Antero Resources with a Buy rating, raising the price target to $50 from $46. The firm emphasized that Antero’s Q4 2025 results position the company to benefit from tightening natural gas markets. Shares currently trade at $33.85, reflecting a potential upside of 15.2% as the energy sector tightens supply dynamics and demand shows resilience.
$CMG Guggenheim maintained a Neutral rating on Chipotle Mexican Grill, noting conservative guidance for 2026 and a flat same-store sales outlook. While the price target was slightly lowered to $36 from $37, the stock trades at $38.72, offering a 34% upside if management meets long-term margin expansion plans.
$DOCS Canaccord Genuity upgraded Doximity from Hold to Buy, calling the post-earnings selloff an overreaction. The price target was reduced to $34, but with shares at $25.45, the potential upside stands at nearly 148%, driven by strong telehealth adoption and long-term growth prospects in healthcare technology.
$FLR Bank of America raised Fluor Corporation’s price target to $47.50 from $43 while maintaining a Neutral rating. At $50.64, the stock has limited upside but is supported by the company’s 2026 outlook in engineering and construction, highlighting project backlog strength.
$LYV Roth Capital reiterated its Buy rating on Live Nation Entertainment, adjusting the price target slightly to $174 from $176. Shares at $155.78 suggest a 23% upside as the live entertainment sector continues benefiting from strong post-pandemic demand and capital inflows into resilient businesses.
$NWS Morgan Stanley maintained an Overweight rating on News Corporation, lowering the target to $32.40 from $38. Shares at $26.28 offer an 18% upside as the firm updates forecasts following fiscal first-half results and media consolidation trends.
$PANW Analysts maintained Buy ratings on Palo Alto Networks while adjusting price targets downward, reflecting Q2 guidance limitations. Shares trade at $152.35 with a 76% potential upside, driven by solid ARR growth and strong demand for cybersecurity solutions despite near-term volatility.
$PBI Pitney Bowes was upgraded from Hold to Buy, reflecting stronger fundamentals. The stock trades at $11.12 with a modest 2% upside to the $11.37 target, suggesting near-term gains may be limited but the operational turnaround is encouraging.
$PLTR Mizuho upgraded Palantir from Sell/Neutral to Outperform, citing AI-driven demand and valuation pullback. Shares at $135.38 have a 75% upside to $236.82, underlining confidence in long-term enterprise AI adoption and data platform expansion.
$PYPL Truist maintained a Hold rating on PayPal, lowering its price target to $39. With shares at $41.45, upside is significant at 82%, although the firm notes payment volume compression may limit near-term gains.
$ROKU Pivotal Research maintained a Buy rating on Roku, raising the price target to $140 from $135. Shares trade at $90.28, implying a 37% upside as the company’s streaming platform demonstrates strong content and ad monetization momentum.
$TVTX Piper Sandler raised its price target for Travere Therapeutics to $38 from $35, maintaining a Buy rating. Shares at $27.87 imply a 19% upside, benefiting from rare disease market growth and strong pipeline positioning.
$VTRS UBS upgraded Viatris to Buy from Neutral, raising the target to $18. Shares trade at $16.05, showing modest upside, supported by efficient capital allocation and steady pharmaceutical profit expansion.
$XYZ Citi maintained a Buy rating on Block, lowering its target to $85. With shares at $53.60, upside sits at 33%, reflecting optimism for payments and fintech adoption trends post-Q4 2025 results.
$Z Susquehanna maintained a Neutral rating on Zillow, reducing the target to $50. The stock trades at $44.98, implying a 68% potential upside as the company executes initiatives effectively in a challenging housing market.
$ZTS Bank of America upgraded Zoetis with a Buy rating, raising the target to $140. Shares at $129.13 have a 4.5% upside, reflecting steady growth in animal health and a strong Q4 performance.
01:03 PM
12:25 PM
12:21 PM
Yesterday at 08:53
Yesterday at 08:39
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 5,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.